Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Moshe Alafi currently holds 3,953,270 shares of Intra-Cellular Therapies, Inc. (ITCI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Moshe Alafi has been a net buyer of ITCI stock. They have purchased $6.5M and sold $100.0K worth of shares.
Moshe Alafi's most recent insider trade was on Oct 2, 2017, when they purchased 258,065 shares at $15.50 per share.
Moshe Alafi serves as Executive at Intra-Cellular Therapies, Inc. (ITCI). They have executed 17 insider transactions totaling $6.6M over their tenure at the company.
Moshe Alafi holds the position of Executive at Intra-Cellular Therapies, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Moshe Alafi has shown a buying trading pattern, with $6.5M in total purchases and $100.0K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Moshe Alafi was on Mar 19, 2007, when they sold $10.9M worth of MDCC shares. This transaction involved 306,040 shares at $35.50 per share.
Moshe Alafi currently owns 3,953,270 shares of Intra-Cellular Therapies, Inc. (ITCI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Moshe Alafi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Moshe Alafi has 17 Form 4 filings on record as an insider at Intra-Cellular Therapies, Inc..
Set alerts for Moshe Alafi and 40,000+ other insiders.